NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Pulmicort Respules on Relapse Rates After Treatment in the ED
Pulmicort Respules on Relapse Rates After Treatment in the ED
WithdrawnPhase 4
Sponsor: Phoenix Children's Hospital
Conditions: Asthma
Interventions: pulmicort respules
Countries: United States
The purpose of this study is to see if the addition of budesonide to oral corticosteroids will result in a decrease in relapse rates compared to oral corticosteroids alone in children who are discharged from the ED after an asthma exacerbation. Secondly, that there will be an improvement in lung function, a decrease in beta-2 agonist use and an improvement in health-related quality of life compared to placebo.
Eligibility overview
Sex: ALL
Age: 2 Years to 8 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: Patient is between the ages of 2 and 8 * Has previously been diagnosed with asthma by any physician * Has presented to the ED with an asthma exacerbation judged by a physician that is believed would not required admission to the hospital Exclusion Criteria: * Children less than 2 years (wheezing may be due to bronchiolitis) * Children who have been on oral or inhaled corticosteroid in the last week, are pregnant, or unavailable for follow-up * Pregnant * Has chronic lung diseases (i.e. cystic fibrosis)
Locations (1)
- Phoenix, Arizona, United States